Articles with public access mandates - Xavier MontalbanLearn more
Not available anywhere: 50
Review
Multiple sclerosis: clinical aspects
J Oh, A Vidal-Jordana, X Montalban
Current opinion in neurology 31 (6), 752-759, 2018
Mandates: Government of Spain
Review
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes
N De Stefano, A Giorgio, M Battaglini, M Rovaris, MP Sormani, F Barkhof, ...
Neurology 74 (23), 1868-1876, 2010
Mandates: US National Institutes of Health
Review
Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis
D Rotstein, X Montalban
Nature Reviews Neurology 15 (5), 287-300, 2019
Mandates: Multiple Sclerosis Society of Canada
Review
Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients
J Rio, A Rovira, M Tintoré, E Huerga, C Nos, N Tellez, C Tur, ...
Multiple Sclerosis Journal 14 (4), 479-484, 2008
Mandates: US National Institutes of Health
Review
Radiologically isolated syndrome: 10‐year risk estimate of a clinical event
C Lebrun‐Frenay, O Kantarci, A Siva, MP Sormani, D Pelletier, DT Okuda, ...
Annals of neurology 88 (2), 407-417, 2020
Mandates: US National Institutes of Health
Review
COVID‐19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response
A Zabalza, S Cárdenas‐Robledo, P Tagliani, G Arrambide, ...
European journal of neurology 28 (10), 3384-3395, 2021
Mandates: Government of Spain
Review
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
S Malhotra, C Costa, H Eixarch, CW Keller, L Amman, ...
Brain 143 (5), 1414-1430, 2020
Mandates: European Commission, Government of Spain
Review
Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis
L Calvo-Barreiro, H Eixarch, X Montalban, C Espejo
Autoimmunity reviews 17 (2), 165-174, 2018
Mandates: Government of Spain
Review
Teriflunomide added to interferon-β in relapsing multiple sclerosis: a randomized phase II trial
MS Freedman, JS Wolinsky, B Wamil, C Confavreux, G Comi, L Kappos, ...
Neurology 78 (23), 1877-1885, 2012
Mandates: Swiss National Science Foundation, US National Institutes of Health
Review
Precision medicine in multiple sclerosis: biomarkers for diagnosis, prognosis, and treatment response
M Comabella, J Sastre-Garriga, X Montalban
Current opinion in neurology 29 (3), 254-262, 2016
Mandates: Government of Spain
Review
Brain atrophy in natalizumab-treated patients: a 3-year follow-up
J Sastre-Garriga, C Tur, D Pareto, A Vidal-Jordana, C Auger, J Río, ...
Multiple Sclerosis Journal 21 (6), 749-756, 2015
Mandates: Government of Spain
Review
The role of the cerebellum in multiple sclerosis—150 years after Charcot
K Parmar, C Stadelmann, MA Rocca, D Langdon, E D'Angelo, M D’Souza, ...
Neuroscience & Biobehavioral Reviews 89, 85-98, 2018
Mandates: Swiss National Science Foundation
Review
Lipid‐specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with …
LM Villar, L Costa‐Frossard, T Masterman, O Fernandez, X Montalban, ...
Annals of neurology 77 (3), 447-457, 2015
Mandates: Government of Spain
Review
Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis
M Tintore, S Otero-Romero, J Río, G Arrambide, B Pujal, C Tur, I Galán, ...
Neurology 87 (13), 1368-1374, 2016
Mandates: Government of Spain
Review
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development
H Hegen, A Millonig, A Bertolotto, M Comabella, G Giovanonni, M Guger, ...
Multiple Sclerosis Journal 20 (5), 577-587, 2014
Mandates: Swiss National Science Foundation, Danish Council for Independent Research
Review
Effect of changes in MS diagnostic criteria over 25 years on time to treatment and prognosis in patients with clinically isolated syndrome
M Tintore, A Cobo-Calvo, P Carbonell, G Arrambide, S Otero-Romero, ...
Neurology 97 (17), e1641-e1652, 2021
Mandates: Government of Spain
Review
Diagnosis of progressive multiple sclerosis from the imaging perspective: a review
M Filippi, P Preziosa, F Barkhof, DT Chard, N De Stefano, RJ Fox, ...
JAMA neurology 78 (3), 351-364, 2021
Mandates: US National Institutes of Health, UK Medical Research Council, National …
Review
Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice
V Abraira, JC Alvarez-Cermeno, R Arroyo, C Cámara, B Casanova, ...
Journal of immunological methods 371 (1-2), 170-173, 2011
Mandates: Government of Spain
Review
Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon‐β treatment
S Malhotra, C Morcillo‐Suárez, R Nurtdinov, J Rio, E Sarro, M Moreno, ...
European Journal of Neurology 20 (10), 1390-1397, 2013
Mandates: Government of Spain
Review
Semaphorin 7A as a potential therapeutic target for multiple sclerosis
A Gutiérrez-Franco, H Eixarch, C Costa, V Gil, M Castillo, L Calvo-Barreiro, ...
Molecular neurobiology 54, 4820-4831, 2017
Mandates: Government of Spain
Publication and funding information is determined automatically by a computer program